Actuate Therapeutics, Inc. ACTU
NASDAQ · United States · Health Technology
$0.8190-0.07 (-7.89%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-14 | -0.20 | -0.20 | +1.6% | $0 | — | +1.5%$0.98→$0.99 |
| Q1 2026 | 2026-05-14 | -0.24 | -0.23 | -4.3% | — | — | -11.8%$2.97→$2.62 |
| Q4 2025 | 2026-03-26 | -0.18 | -0.24 | +25.0% | — | — | -7.3%$2.32→$2.15 |
| Q3 2025 | 2025-11-13 | -0.25 | -0.27 | +7.4% | — | — | -6.2%$6.30→$5.91 |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.